ABCA3 and glioblastoma: The lysosome‐associated ABC transporter A3 (ABCA3) regulates exosome biogenesis and ABCA3 depletion enhances the sensitivity of target cells to antibody‐mediated cytotoxicity.[10a] Similarly, bevacizumab is captured by glioblastoma (GBM) cells derived EVs.